SciELO - Scientific Electronic Library Online

 
vol.28 issue6Spatial analysis of domestic violence against women from 2002 to 2005 in João Pessoa, Paraíba State, BrazilFactors associated with adequate fruit and vegetable intake by schoolchildren in Santa Catarina State, Brazil author indexsubject indexarticles search
Home Page  

Cadernos de Saúde Pública

Print version ISSN 0102-311X

Abstract

VIANNA, Carolina Avila; GONZALEZ, David Alejandro  and  MATIJASEVICH, Alicia. Aspirin use in cardiovascular disease prevention: a population-based study. Cad. Saúde Pública [online]. 2012, vol.28, n.6, pp. 1122-1132. ISSN 0102-311X.  http://dx.doi.org/10.1590/S0102-311X2012000600011.

The objective of this study was to estimate the prevalence of aspirin use in primary and secondary prevention of cardiovascular disease. A population-based cross-sectional study was conducted in Pelotas, Rio Grande do Sul State, Brazil, from January to May 2010. The study had two outcomes: 1) aspirin use in primary prevention (individuals > 40 years of age with at least two risk factors: hypertension, diabetes mellitus, and/or hyperlipidemia) and 2) aspirin use in secondary prevention (history of stroke and/or angina/myocardial infarction). The outcomes were analyzed based on demographic, socioeconomic, and lifestyle variables. Prevalence of aspirin use was 24.8% for primary prevention and 34.3% for secondary prevention. In primary prevention, aspirin use was more common in non-whites and older individuals and among those with worse self-rated health. For secondary prevention, aspirin use was more frequent among older and higher-income individuals and former smokers. Prevalence of aspirin use was well below recommended levels for prevention of cardiovascular diseases.

Keywords : Cardiovascular Diseases; Acetylsalicylic Acid; Disease Prevention.

        · abstract in Portuguese     · text in Portuguese     · pdf in Portuguese